Showing that RV and allergen interact to enhance NF-κB p65 and airways inflammation, and by comparing RV infection in p65 gene-deficient mice has, for the first time, provided clear evidence that suppressing p65 is an attractive anti-inflammatory approach for asthma exacerbations that will not impair host antiviral defence. The gene discussed is NFKB1; the disease is asthma.